Vutrisiran Uses, Dosage, Side Effects and more
Vutrisiran is an investigational RNAi therapeutic in development for the treatment of transthyretin-mediated (ATTR) amyloidosis, which encompasses both hereditary ATTR (hATTR) amyloidosis and wild-type ATTR (wtATTR) amyloidosis.
| Trade Name | Vutrisiran |
| Generic | Vutrisiran |
| Vutrisiran Other Names | Votrisiran, Vutrisiran |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
